本頁面由Tiger Trade Technology Pte. Ltd.提供服務

ICU醫療

124.19
-3.4600-2.71%
盤前124.520.3300+0.27%04:46 EDT
成交量:23.25萬
成交額:2,888.95萬
市值:30.66億
市盈率:4,180.50
高:127.69
開:126.75
低:123.20
收:127.65
52周最高:160.29
52周最低:107.00
股本:2,468.67萬
流通股本:2,390.20萬
量比:0.72
換手率:0.97%
股息:- -
股息率:- -
每股收益(TTM):0.0297
每股收益(LYR):0.0297
淨資產收益率:0.04%
總資產收益率:1.66%
市淨率:1.44
市盈率(LYR):4,180.50

資料載入中...

2025/02/28

重要事件披露

Form 8-K - Current report
2025/01/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/12/06

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/12/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/11/27

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/11/25

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/11/12

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/11/12

重要事件披露

Form 8-K - Current report
2024/11/08

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/01

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/10/03

重要事件披露

Form 8-K - Current report
2024/10/01

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/09/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/08/30

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/08/16

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/08/14

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/08/08

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/08/07

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/08/07

重要事件披露

Form 8-K - Current report
2024/07/18

超過5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]